Nuvectis Pharma, Inc. NVCT Business Segments — Professional Fees
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Nuvectis Pharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProfessionalFees.
The official record: Nuvectis Pharma, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvectis Pharma, Inc.'s business segments — professional fees.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvectis Pharma, Inc.'s business segments — professional fees?
- Nuvectis Pharma, Inc. (NVCT) reported business segments — professional fees of $1.16M in Q1 2026.
- How has Nuvectis Pharma, Inc.'s business segments — professional fees changed year-over-year?
- Nuvectis Pharma, Inc.'s business segments — professional fees increased by 20.9% year-over-year, from $957K to $1.16M.
- What is the long-term trend for Nuvectis Pharma, Inc.'s business segments — professional fees?
- Over 2 years (2023 to 2025), Nuvectis Pharma, Inc.'s business segments — professional fees has grown at a 18.4% compound annual growth rate (CAGR), from $3.74M to $5.24M.
- What does business segments — professional fees mean?
- Payments made to external consultants, legal advisors, and specialized service providers supporting clinical development operations. These fees represent the reliance on third-party expertise to navigate regulatory and operational hurdles.